Where does Rio Grande Neurosciences, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Rio Grande Neurosciences, Inc. ranks #29,944 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Rio Grande Neurosciences, Inc. hold?

Rio Grande Neurosciences, Inc. holds 9 US utility patents granted between 2016 and 2017, spanning 5 technology areas.

What is Rio Grande Neurosciences, Inc.'s Innovation Score?

Rio Grande Neurosciences, Inc. has an Innovation Score of 30.9 out of 100 (36th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Rio Grande Neurosciences, Inc.'s patent grant rate increasing or decreasing?

Rio Grande Neurosciences, Inc.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Rio Grande Neurosciences, Inc.'s patents?

Rio Grande Neurosciences, Inc.'s patents average 25.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Rio Grande Neurosciences, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Rio Grande Neurosciences, Inc.

Q: What technology areas does Rio Grande Neurosciences, Inc. focus on?

Rio Grande Neurosciences, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 9 patents. Grants appear in 5 CPC subclasses total.

USPTO PatentsView assignee record - 9 granted patents across 5 technology areas, recorded in grant years 2016–2017. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Rio ranks #29,944 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 5 technology areas.

#29,944
of 49,997 US assignees by volume: 36th percentile
by Innovation Score (30.9/100): 25.9
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R29944 · US Corporation #29,944 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 9 grants
MID-PACK #29,944/49,997
PHOTO-FINISH Reverse Ionizer…
CPC-NARROW A61N · 5 areas
INNOV-THIN 30.9/100
CLAIMS-DENSE 25.9 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Reverse Ionizer Systems, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Rio Grande Neuroscie… · this assignee

31
3D Lighting… · lowest

7

What this shows Rio's Innovation Score is 30.9/100 (36th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Rio's grants concentrate

Rio Grande Neurosciences, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2016 (8 grants) versus a trough of 1 in 2017. By volume, Rio sits between Reverse Ionizer Systems, LLC and RnD-ISAN, Ltd.

Reverse Ionizer S…

9
Ri MED Foundation

9
Rideflux

9
Rimports

9
Riva Health

9
Rive Technology

9
Riverside Researc…

9
Rnd-isan

9
Rio Grande Neuros… ◀

9

What this shows Rio holds 9 patents at rank #29,934, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Rio

By rank, the assignees closest to #29,934 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Rio's primary technology class.

Rio's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 36th percentile higher than 36% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2017

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Rio Grande Neurosciences, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	8	88.9%
2017	1	11.1%

Which technologies does Rio Grande Neurosciences, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 9

A01G - HORTICULTURE; Cultivation OF Vegetables, Flowers, Rice, Fruit, Vines, Hops OR SEAWEED; FORESTRY; Watering 1

A42B - HATS; Head Coverings 1

A41D - OUTERWEAR; Protective GARMENTS; Accessories 1

A47G - Household OR Table Equipment 1

Top 5 of 5 technology areas

Where it ranks

Overall rank by patents

#29,944

of 49,997 tracked assignees

Innovation Score

30.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Rio Grande Neurosciences, Inc.'s patent record in context - here's where to go next.

Rio Grande Neurosciences, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 100% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #29,944 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Rio Grande Neurosciences, Inc. against Reverse Ionizer Systems, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.